Visbiome

ExeGi Pharma, the makers of Visbiome®, is a biotechnology company focused on developing and commercialization of live biotherapeutic and probiotic medicines. 

Visbiome is a non-drug therapy that addresses distinct nutritional requirements to promote microbial balance that cannot be addressed by modifying the diet alone. Visbiome is a high potency probiotic medical food intended for the dietary management of dysbiosis associated with irritable bowel syndrome (IBS), ulcerative colitis (UC), antibiotic-associated diarrhea (AAD), Hepatic Encephalopathy, and pouchitis. Visbiome is a unique blend of 8 strains of bacteria, a formulation with more than 75 clinical trials and more than 20 years of research, making it one of the most studied probiotic formulations on the market.